OTC Markets OTCPK - Delayed Quote USD
Halberd Corporation (HALB)
0.0025
+0.0001
+(4.17%)
As of 12:30:09 PM EDT. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. William A. Hartman | President, CEO & Chairman | -- | -- | 1942 |
| Mr. John S. Borza AVS, MBA, PE | COO & Director | -- | -- | 1954 |
| Ms. Heidi H. Carl | Director & Accounting Director | -- | -- | 1971 |
| Dr. Mitchell S. Felder M.D. | CTO & Member of the Scientific Advisory Board | -- | -- | 1954 |
| Dr. Patricio F. Reyes FAAN, M.D. | Chief Mechanical Officer & Member of the Scientific Advisory Board | -- | -- | 1947 |
Halberd Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Corporate Governance
Halberd Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
January 3, 2023 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
September 22, 2022 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
Related Tickers
CNBX CNBX Pharmaceuticals Inc.
0.0010
+11.11%
TNGNQ Tengion, Inc.
0.0001
+900.00%
FPMI FluoroPharma Medical, Inc.
0.0001
0.00%
USRM U.S. Stem Cell, Inc.
0.0001
0.00%
RLF.SW Relief Therapeutics Holding SA
2.2700
+0.22%
RLFTF Relief Therapeutics Holding SA
2.7750
+1.91%
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
DTC.CN Defence Therapeutics Inc.
0.7900
0.00%
ZLDPF Zealand Pharma A/S
74.13
0.00%
PBLA Panbela Therapeutics, Inc.
0.2600
+7.48%